Related Experiment Video
Updated: Jun 21, 2026
12:02
An Efficient Method for the Synthesis of Peptoids with Mixed Lysine-type/Arginine-type Monomers and Evaluation of Their Anti-leishmanial Activity
Published on: November 2, 2016
Design and facile solid-phase synthesis of peptide-based LPS-inhibitors containing PEG-like functionalities
Carlos Mas-Moruno1, Laura Cascales, Puig Mora
1Institute for Research in Biomedicine, Barcelona Science Park, University of Barcelona, Barcelona 08028, Spain.
Biopolymers
|July 29, 2009
Summary
New peptide-based inhibitors effectively neutralize lipopolysaccharide (LPS), a key trigger of sepsis. Incorporating PEG-like moieties enhances inhibitor activity, offering a promising strategy for sepsis treatment development.
Area of Science:
- Biochemistry
- Immunology
- Medicinal Chemistry
Background:
- Lipopolysaccharide (LPS) from Gram-negative bacteria triggers sepsis, a life-threatening condition.
- Current treatments necessitate novel, safe, and easily synthesized LPS inhibitors.
- Lipid A, the toxic component of LPS, is a target for inhibitor design.
Purpose of the Study:
- To develop novel peptide-based LPS neutralizers.
- To investigate the role of PEG-like moieties in LPS inhibitor activity.
- To create new therapeutic agents for sepsis treatment.
Main Methods:
- Solid-phase peptide synthesis methodologies were employed.
- Peptide derivatives incorporating PEG-like moieties were synthesized.
- The anti-LPS activity of synthesized compounds was evaluated.
Main Results:
- Peptide-based LPS neutralizers were successfully synthesized.
- Compounds featuring PEG-like moieties demonstrated enhanced activity.
- A modified cyclic anti-LPS peptide (RLKWc derivative) retained its efficacy.
Conclusions:
- PEG-like functionalities are valuable for designing potent LPS inhibitors.
- This strategy can be applied to other LPS-neutralizing peptides.
- Developed inhibitors show potential for sepsis therapeutic development.
